Ledger.Open graph →
SEC Form D · filed August 12, 2020

RespireRx Pharmaceuticals Inc

Offering
$193K
Sold
$193K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Arnold S. Lippa · Glen Rock, NJExec · DirectorRichard E. Purcell · Glen Rock, NJExecJeff E. Margolis · Glen Rock, NJExec · DirectorKathryn E. Macfarlane · Glen Rock, NJDirectorTimothy E. Jones · Glen Rock, NJExec · DirectorDonald R. Mclamb, Jr · Wilmington, DEExecGlenn R. Hanson · Wilbraham, MAExec · DirectorWilliam S. Seybold · San Fransisco, CAExec · DirectorPeter Mullen · New York, NYDirectorLuke J. Atwood · Richmond, VAExec · DirectorAndrew F. St Pierre · Burlington, MAExec · DirectorCharles Berg · New York, NYExec · DirectorChristine K. Funk · Sisters, ORExecMatt Harris · New York, NYDirectorRichard Ferrari · Los Gatos, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗